Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its ambitious plans for the 2024 calendar year. In his annual letter, Chris Bunka, Lexaria’s CEO, noted that this would mark the year that will prove all of the company’s work of producing hard, factual scientific information worth it, accomplishments that were […]

We’ve known this was coming, for a very long time. For well over a decade, various experts have been warning governments and industry about global over-reliance on China for the supply of rare earth elements (REE). Now, this day of reckoning has arrived. Beginning in the spring of 2023, China first “threatened” to impose restrictions […]

Electronic Servitor Publication Network (OTCQB: XESP) is a digital engagement company that, through its digital activation and customer engagement solutions, provides B2B companies with intelligent interaction management, dynamic content provisioning, and a logic-driven workflow that creates dynamic digital experiences. Targeting multiple verticals, the company aims to accelerate client companies’ audiences from awareness to action, driving […]

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is a Canadian natural resource development and exploration company that targets high-grade nickel sulfide discoveries for use in the rapidly growing global electric vehicle (“EV”) market. The company has a portfolio of two high-quality exploration projects located in the prolific Trans Hudson Corridor in Saskatchewan. Led by […]

Correlate Energy (OTCQB: CIPI), a publicly traded company is capitalizing on America’s growing trend toward renewables and increased energy efficiency. As such, it is positioning itself as the one-stop go-to company, for companies seeking more significant participation in renewables, cost savings, and an overall reduction in their carbon footprint. Most recently, corporations such as Continental […]

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions including hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-related Frailty has evaluated – and still is evaluating – its lead investigational therapeutic candidate Lomecel-B(TM), an allogeneic, bone marrow-derived medicinal signaling cell (“MSC”) therapy product, in multiple clinical trials. One […]

Turbo Energy (NASDAQ: TURB), a photovoltaic energy storage innovator, has started the new year on a high note with a strategic alliance announcement. The company has forged a collaboration with Solar360, a joint venture of Repsol and Telefónica España, signaling a promising beginning for Turbo Energy in 2024. In this partnership, Turbo Energy will supply […]

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, recently reported new results from the open-label long-term extension (“LTE”) of the VISIONARY-MS trial (https://ibn.fm/5QSDO). This was a double-blind, placebo-controlled Phase 2 clinical trial comprised of participants […]

In a space where a growing number of individuals are qualifying for Medicare, Astiva Health is differentiating itself as a fast-growing Medicare Advantage Prescription Drug (“MAPD”) health plan focused on redefining the standards of personalized and comprehensive healthcare. As an indication of its success in, Astiva company recently reached a key milestone, surpassing the 10,000-member […]

Salt Lake City-based Diamond Lake Minerals (OTC: DLMI) is dedicated to providing modern investors with a bridging strategy for accessing meaningful digital assets as a healthy part of their investment portfolios. Digital assets can be discouraging to traditional investors comfortable with putting their money into established real assets that don’t appear to have the amount […]